Literature DB >> 12084190

The effect of 15-lipoxygenase-1 expression on cancer cells.

Uddhav Kelavkar1, Wayne Glasgow, Thomas E Eling.   

Abstract

Lipoxygenases oxidatively metabolize polyunsaturated fatty acids to a rich spectrum of biologically active products. One enzyme of the lipoxygenase family, Arachidonate 15-lipoxygenase-1 (arachidonate:oxygen 15-oxidoreductase, EC 1.13.11.33), is implicated in several forms of epithelial cell cancers, and provides a rationale for exploring its role in the progression and metastasis of cancers. Thus, 15-LO-1 could be a marker of the growth and spread of cancers. The importance of 15-LO-1 expression is imparted by its metabolic product of linoleic acid, yielding 13-(S)-hydroxyoctadecadienoic acid (13-(S)-HODE). In order to maximize our understanding of the roles of lipoxygenases and cyclooxygenases in cancer, it is necessary to correlate their metabolic pathways to the respective expression levels, and not exaggerate the presence or absence of an enzyme or its function when it clearly is not there. It is also important to acknowledge that some forms of these enzymes may not even be relevant to human disease. Although it is unlikely that any single gene is sufficient to account for the complex etiology of cancer, 15-LO-1 overexpression is clearly a key component in the cell proliferation process. This article is divided into three sections emphasizing the key role of 15-LO-1 in prostate, colorectal, and breast cancers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12084190     DOI: 10.1007/s11934-002-0066-8

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  49 in total

1.  13(S)-HpODE augments epidermal growth factor signal transduction by attenuating EGF receptor dephosphorylation.

Authors:  W C Glasgow; R Hui; S Jayawickreme; J Angerman-Stewart; B B Han; T E Eling
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

2.  Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging.

Authors:  U P Kelavkar; C Cohen; H Kamitani; T E Eling; K F Badr
Journal:  Carcinogenesis       Date:  2000-10       Impact factor: 4.944

3.  Modulation of the epidermal growth factor mitogenic response by metabolites of linoleic and arachidonic acid in Syrian hamster embryo fibroblasts. Differential effects in tumor suppressor gene (+) and (-) phenotypes.

Authors:  W C Glasgow; C A Afshari; J C Barrett; T E Eling
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

4.  15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.

Authors:  S B Shappell; R A Gupta; S Manning; R Whitehead; W E Boeglin; C Schneider; T Case; J Price; G S Jack; T M Wheeler; R J Matusik; A R Brash; R N Dubois
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

5.  Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase.

Authors:  H S Camp; S R Tafuri
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

6.  Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator gene.

Authors:  U P Kelavkar; K F Badr
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

7.  Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase.

Authors:  W C Glasgow; E M Hill; S R McGown; K B Tomer; T E Eling
Journal:  Mol Pharmacol       Date:  1996-06       Impact factor: 4.436

Review 8.  William L. McGuire Memorial Symposium. The role of erbB2 signal transduction pathways in human breast cancer.

Authors:  R Lupu; M E Lippman
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

9.  Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer.

Authors:  X Gao; D J Grignon; T Chbihi; A Zacharek; Y Q Chen; W Sakr; A T Porter; J D Crissman; J E Pontes; I J Powell
Journal:  Urology       Date:  1995-08       Impact factor: 2.649

10.  Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma.

Authors:  H Kamitani; S Taniura; H Ikawa; T Watanabe; U P Kelavkar; T E Eling
Journal:  Carcinogenesis       Date:  2001-01       Impact factor: 4.944

View more
  13 in total

1.  15-Lipoxygenase 1 interacts with phosphatidylethanolamine-binding protein to regulate MAPK signaling in human airway epithelial cells.

Authors:  Jinming Zhao; Valerie B O'Donnell; Silvana Balzar; Claudette M St Croix; John B Trudeau; Sally E Wenzel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-09       Impact factor: 11.205

2.  Prostate tumor growth can be modulated by dietarily targeting the 15-lipoxygenase-1 and cyclooxygenase-2 enzymes.

Authors:  Uddhav P Kelavkar; Justin Hutzley; Kevin McHugh; Kenneth G D Allen; Anil Parwani
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

3.  Induction of apoptosis by Trichostatin A in human breast cancer cell lines: involvement of 15-Lox-1.

Authors:  Masoumeh Tavakoli-Yaraki; Fatemeh Karami-Tehrani; Vahid Salimi; Majid Sirati-Sabet
Journal:  Tumour Biol       Date:  2012-10-06

4.  Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model.

Authors:  Uddhav P Kelavkar; Anil V Parwani; Scott B Shappell; W David Martin
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

5.  Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy.

Authors:  Uddhav P Kelavkar; Justin Hutzley; Rajiv Dhir; Paul Kim; Kenneth G D Allen; Kevin McHugh
Journal:  Neoplasia       Date:  2006-02       Impact factor: 5.715

6.  15-lipoxygenase-1 activates tumor suppressor p53 independent of enzymatic activity.

Authors:  Hong Zhu; Wayne Glasgow; Margaret D George; Kali Chrysovergis; Kenneth Olden; John D Roberts; Thomas Eling
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

7.  SAR comparative studies on pyrimido[4,5-b][1,4] benzothiazine derivatives as 15-lipoxygenase inhibitors, using ab initio calculations.

Authors:  Mehdi Bakavoli; Hamid Sadeghian; Zahra Tabatabaei; Elham Rezaei; Mohammad Rahimizadeh; Mohsen Nikpour
Journal:  J Mol Model       Date:  2008-04-19       Impact factor: 1.810

8.  15-lipoxygenase-1 expression upregulates and activates insulin-like growth factor-1 receptor in prostate cancer cells.

Authors:  Uddhav P Kelavkar; Cynthia Cohen
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

9.  Fatty acid metabolites in rapidly proliferating breast cancer.

Authors:  Joseph T O'Flaherty; Rhonda E Wooten; Michael P Samuel; Michael J Thomas; Edward A Levine; L Douglas Case; Steven A Akman; Iris J Edwards
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

10.  New Insight into the SAR of Pyrimido [4,5-b][1,4] Benzothiazines as 15-lipoxygenase Inhibitors.

Authors:  Nona Pooryaghoobi; Mehdi Bakavoli; Maliheh Alimardani; Tahmineh Bazzazan; Hamid Sadeghian
Journal:  Iran J Basic Med Sci       Date:  2013-06       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.